CTOs on the Move

New Jersey Organ and Tissue

www.sharenj.org

 
New Jersey Organ and Tissue is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New Jersey Organ and Tissue is based in New Providence, NJ. You can find more information on New Jersey Organ and Tissue at www.sharenj.org
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.sharenj.org
  • 691 Central Ave
    New Providence, NJ USA '07974
  • Phone: 800.742.7365

Executives

Name Title Contact Details

Similar Companies

Assisted Living Concepts

Assisted Living Concepts, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Assisted Living Concepts, Inc. is based in Menomonee Falls, WI. You can find more information on Assisted Living Concepts, Inc. at www.alcco.com

HCSC

HCSC is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedOne

MedOne unlocks the most appropriate prescription at the most affordable price for organizations and their health plan members nationwide. The MedOne model delivers real prescription savings by cutting out the traditional "PBM" middlemen and facilitating direct relationships between health plans and high-performing pharmacies. Once we establish a transparent and aligned marketplace, we partner with organizations to optimize "where" and "what" members fill to reduce pharmacy costs and improve health outcomes. Ready for a new approach to pharmacy benefits? We invite you to experience the difference!

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Hillsboro Medical Ctr

Hillsboro Medical Ctr is a Hillsboro, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.